Morepen receives USFDA approval for Montelukast Sodium
Morepen Laboratories has received USFDA approval for Montelukast Sodium, a bulk drug which is used in treatment of asthma and respiratory disorders. The drug market […]
Month: January 2018
Panacea Biotech signs agreement with Serum Institute for vaccine production
Panacea Biotec has signed an agreement with Serum Institute of India (SII) and its wholly owned subsidiary, Bilthovan Biologicals B.V. (BBIO). Under the agreement, SII […]
Torrent Pharma acquires US based Bio Pharm Inc
Torrent plans has acquired the Bio-Pharm, Inc. (BPI) – a US-based generic pharmaceuticals and OTC company, The Bio-Pharm, Inc. (BPI). Was established in 1992 and […]
Ipca Laboratories acquires Pisgah Labs Inc, USA
Ipca Laboratories have acquired the US-based Pisgah Labs Inc for $9.65 million. Pisgah is a contract manufacturer and developer of active pharmaceutical ingredients (APls) and […]
Glenmark Pharma launches Adalimumab in India
Glenmark Pharmaceuticals has launched the biosimilar drug Adalimumab in India. The drug will be marketed under a licensing agreement with Cadila Healthcare Ltd. It is […]